IRIS
VERITTI, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.088
EU - Europa 1.314
AS - Asia 893
SA - Sud America 132
AF - Africa 10
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.442
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.048
SG - Singapore 533
UA - Ucraina 316
IT - Italia 264
DE - Germania 174
CN - Cina 173
RU - Federazione Russa 168
BR - Brasile 124
FI - Finlandia 97
IE - Irlanda 88
TR - Turchia 69
SE - Svezia 55
GB - Regno Unito 41
CA - Canada 31
FR - Francia 29
KR - Corea 26
NL - Olanda 22
VN - Vietnam 22
IN - India 21
AT - Austria 17
BE - Belgio 15
HK - Hong Kong 15
JP - Giappone 11
PL - Polonia 9
PK - Pakistan 6
TG - Togo 6
MX - Messico 5
BD - Bangladesh 4
UZ - Uzbekistan 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
PT - Portogallo 3
RO - Romania 3
AU - Australia 2
BO - Bolivia 2
EU - Europa 2
LU - Lussemburgo 2
MA - Marocco 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
GE - Georgia 1
GL - Groenlandia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 7.442
Salva come PNG Salva come JPEG
Città #
Woodbridge 666
Fairfield 621
Ann Arbor 468
Houston 430
Chandler 429
Ashburn 323
Singapore 281
Seattle 244
Wilmington 240
Cambridge 189
Jacksonville 187
Boardman 147
Dearborn 132
Princeton 94
Dublin 88
Beijing 68
Izmir 68
Udine 56
San Diego 39
Ogden 28
Norwalk 26
Seoul 26
New York 25
Falls Church 23
Belluno 21
Des Moines 21
Dong Ket 20
Ottawa 20
Los Angeles 17
Brussels 15
Düsseldorf 14
Grafing 14
Santa Clara 12
Frankfurt am Main 10
Hefei 10
Nanjing 9
Redmond 9
Rome 9
Warsaw 9
Bologna 8
Hong Kong 8
Jinan 8
Milan 8
Treviso 8
Vienna 8
Wuhan 8
Guangzhou 7
Kunming 7
Lauterbourg 7
Paese 7
São Paulo 7
Toronto 7
Helsinki 6
Lappeenranta 6
Lomé 6
Nanchang 6
Nuremberg 6
Rio de Janeiro 6
Shenzhen 6
Trieste 6
Amsterdam 5
Belo Horizonte 5
Chengdu 5
Munich 5
Naples 5
Phoenix 5
Shanghai 5
Vicenza 5
Andover 4
Chioggia 4
Council Bluffs 4
Nakano 4
Paris 4
Portsmouth 4
Tashkent 4
Tokyo 4
Brooklyn 3
Campinas 3
Camponogara 3
Chicago 3
Cividale Del Friuli 3
Hyderabad 3
London 3
Shenyang 3
Stockholm 3
Turin 3
Venezia 3
Wenzhou 3
Agugliano 2
Baotou 2
Bari 2
Buffalo 2
Conegliano 2
Dhaka 2
Edinburgh 2
Florianópolis 2
Fuzhou 2
Hortolândia 2
Ibirité 2
Indiana 2
Totale 5.386
Salva come PNG Salva come JPEG
Nome #
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 156
A case of CRB1-negative Coats-like retinitis pigmentosa 143
Fluocinolone acetonide for the treatment of diabetic macular edema 139
Proliferative Diabetic Retinopathy: Treatment Update 138
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 132
Advances in pharmacotherapy for wet age-related macular degeneration 131
Effects of VEGF inhibition on retinal morphology, neovascular network size, and visual acuity in patients with vascularized pigment epithelium detachment because of occult choroidal neovascularization. 127
Online optical coherence tomography during subthreshold laser irradiation 126
Triple therapy for corneal neovascularization: A case report 125
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 125
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 124
Major ocular complications after organ transplantation 123
Neovascular age-related macular degeneration 123
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 121
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 119
Dexamethasone implant in diabetic macular edema in real-life situations 119
Optical coherence tomography angiography findings in diabetic retinopathy 117
Fundus autofluorescence applications in retinal imaging 116
Low-concentration infracyanine green-assisted internal limiting membrane peeling in idiopathic macular pucker 25-gauge surgery 113
Intravitreal injections: a healthcare failure modes and effects analysis. 113
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 113
Author’s response 112
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: An in vitro study 112
Update on combination therapy in wet age-related macular degeneration 111
Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: One-year follow-up 109
Selective laser trabeculoplasty 108
Functional and morphological changes after macular pucker surgery: An optical coherence tomography and microperimetric study 108
Drug safety evaluation of intravitreal triamcinolone acetonide 106
Non-proliferative diabetic retinopathy 104
Ocular complications after hand transplantation 102
Pharmacotherapy for treatment of retinal vein occlusion. 102
Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study 102
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 101
Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: Impact of different photodynamic therapy parameters 100
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: A literature review 97
Trauma and emergencies 90
Triamcinolone acetonide for the treatment of diabetic macular oedema 90
Diabetic macular edema 89
Regression of diabetic macular edema after subcutaneous exenatide. 89
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 89
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 89
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 88
Intravitreal steroids for the treatment of retinal diseases. 87
One-year outcome of ranibizumab for neovascular age-related macular degeneration: a thorough analysis in a real-world clinical setting. 86
null 85
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 82
Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion. 81
Experience with the Pascal® photocoagulator: An analysis of over 1200 laser procedures with regard to parameter refinement 80
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 78
Macular pucker 77
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 77
Steroids in a Combination Strategy 73
Vascular Anomalies of the Fundus Oculi: Diagnosis and Treatment 71
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 69
null 61
Intraocular pressure (IOP) after intravitreal dexamethasone implant (Ozurdex) amongst different geographic populations—GEODEX-IOP study 61
Impact on quality of life 58
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 58
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 57
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 53
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 53
The Present and Future of Optic Pathway Glioma Therapy 49
Subthreshold laser 48
Edema maculare post occlusione venosa 48
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 47
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 46
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 43
Color fundus autofluorescence to determine activity of macular neovascularization in age-related macular degeneration 43
Occhio 41
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 40
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 38
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 38
Stem cell therapy in retinal diseases: current evidence 37
Present Status of Laser Therapy: Role of Subthreshold Laser 37
The role of steroids in the treatment of diabetic macular edema 37
Diabetic macular edema 37
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 37
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 36
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 36
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 36
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes 35
Ranibizumab in neovascular age-related macular degeneration: an as-needed treatment regimen with bimonthly evaluation 34
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 33
Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose 32
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 32
Surgical Management for Diabetic Macular Edema 31
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 31
OCT angiography in chronic central serous chorioretinopathy 31
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 31
Long-term Effect of Intravitreal Bevacizumab on Chorioretinal Atrophy Progression in Myopic Choroidal Neovascularization 30
Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study 30
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 29
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study 26
Vitrectomy in Small idiopathic MAcuLar hoLe (SMALL) study: conventional internal limiting membrane peeling versus inverted flap 25
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 25
Macular Holes 24
Response to:Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 22
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination 21
Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema 21
One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa 21
Totale 7.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.184
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 0 0 0 0 0 0 0 0 0 0 34 171
2020/2021926 43 110 56 121 45 92 38 98 124 36 100 63
2021/2022655 31 41 21 18 25 39 54 34 18 119 134 121
2022/2023925 120 64 12 140 91 234 0 70 119 9 32 34
2023/2024323 66 22 6 8 40 35 13 28 45 21 2 37
2024/20251.411 37 121 111 87 39 79 138 87 230 193 289 0
Totale 7.733